Rodger Novak Crispr Therapeutics Ag (CRSP) insider trading activity
Rodger Novak is President of CRISPR Therapeutics AG. Currently has a direct ownership of 573,007 shares of CRSP, which is worth approximately $25.9 Million. The most recent transaction as insider was on May 30, 2017, when has been sold 3,650 shares (Common Shares) at a price of $15.02 per share, resulting in proceeds of $54,823. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
573K
0%
3M change
0%
12M change
Total Value Held
$25.9 Million
Rodger Novak Transaction History
RN
Rodger Novak
President
Cambridge, MA